News

Pharmaceutical giants introduce an insurance-free pathway for top anticoagulant Eliquis, following similar direct-to-patient ...
The joint venture is launching a direct-to-consumer service of Eliquis after discussions with the Trump administration.
The program, available through the companies’ Eliquis 360 Support platform, will launch September 8 for eligible uninsured, underinsured, or self-pay patients with an Eliquis prescription. The service ...
A 30-day supply of Eliquis currently has a list price of $606, but would cost $346 per month under the new program, according to a report from the Wall Street Journal. Since its approval in 2012 ...
BMS and Pfizer have established a direct-to-patient online program, Eliquis 360 Support, which offers the blood thinner at a discount price.
Pfizer and Bristol Myers Squibb have launched a direct-to-patient program offering their blood thinner Eliquis at a 40% discount for cash-paying patients. The list price for Eliquis (apixaban) is ...
Pfizer, Inc. (NYSE:PFE) is one of the high-margin pharma stocks to buy now. Bristol-Myers Squibb Company (NYSE:BMY) and Pfizer, Inc. (NYSE:PFE) have announced a direct-to-patient program for ...
Pfizer, Inc. (NYSE:PFE) is one of the high-margin pharma stocks to buy now. Bristol-Myers Squibb Company (NYSE:BMY) and Pfizer, Inc. (NYSE:PFE) have announced a direct-to-patient program for Eliquis ...
(Reuters) -Bristol Myers and Pfizer said on Thursday they will start selling their blockbuster blood thinner, Eliquis, directly to cash-paying U.S. patients at a discount to its listed price as ...
Bristol Myers Squibb (BMY) and Pfizer (PFE) announced a discount of over 40% on their blood thinner drug Eliquis when purchased through the alliance’s patient resource platform, Eliquis 360 Support. U ...
Bristol Myers Squibb, Pfizer to sell blockbuster blood thinner Eliquis at 40% discount By Annika Kim Constantino, CNBC • Published July 17, 2025 • Updated on July 17, 2025 at 12:00 pm ...
The report, citing a source, stated that the Bristol-Pfizer partnership opted to launch direct sales of Eliquis following discussions with the Trump administration about making the drug more ...